Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No price history available for this symbol yet.
No one on the platform currently holds GCL.TO.
No tracked institution reports a position in GCL.TO as of their last filing.
No one on the platform has traded GCL.TO yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $907M | +15.6% | $-0.01 | $-0.01–$-0.01 | — | 2 |
| 2027 | $933M | +2.9% | $0.19 | $0.18–$0.20 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 1 of the last 4 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2025-10-16 | $-0.01 | $-0.73 | -5740.0% |
| 2025-04-30 | $-0.02 | $-0.04 | -100.0% |
| 2024-10-17 | $0.01 | $0.01 | -33.3% |
| 2024-07-24 | $0.01 | $0.02 | +61.4% |
| +0.00% |
| $5M |
| — |
| EBM.VEastwood Bio-Medical Canada Inc. | $1.71 | +10.32% | $118M | — |
| JSDA.CNJones Soda Co. | $0.44 | +0.00% | $55M | — |
Source: Financial Modeling Prep · peers by sector/industry